Financials
- Market Capitalization 12.68 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-34.99
Fiyat/satışlar oranı
11.04
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 706 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 240.30 USD | +0.95% | -2.59% | +4.08% | +71.64% | 15.08 B USD | ||
| 740 | EXEL Exelixis, Inc. - Common Stock | 55.79 USD | +0.04% | +0.22% | +4.59% | +42.90% | 14.02 B USD | ||
| 820 | SMMT Summit Therapeutics Inc. - Common Stock | 15.09 USD | -2.46% | -3.70% | +6.87% | -24.02% | 11.71 B USD | ||
| 824 | AXSM Axsome Therapeutics, Inc. - Common Stock | 235.91 USD | +0.28% | -5.28% | -7.50% | +81.19% | 12.14 B USD |